Published 4 years ago

Gantz: Israeli COVID-19 vaccine to begin human trials by month’s end

Summary by The Times of Israel

Defense minister says vaccine will be called 'Brilife,' a portmanteau of life and the Hebrew word for health, bri'ut

0 Articles

All

Left

Center

Right

Yahoo News

Coronavirus update: Pfizer seeks vaccine authorization in November; Medicare cuts delayed COVID-19 testing payments

Pfizer seeks emergency use authorization in November despite anticipating results of its COVID-19 vaccine in October.

3 years ago·Los Angeles, United States

Read Full Article

News18 India

Pfizer, BioNTech Start Combined Trials Of COVID-19 Vaccine Candidate In Japan

Pfizer Inc and BioNTech SE announced on Tuesday the start in Japan of combined Phase I and Phase II clinical trials of their mRNA vaccine candidate against the coronavirus.

3 years ago·India

Read Full Article

The Hindu

Israel to start human trials of COVID vaccine candidate ‘Brilife’ towards October

Defence Minister Benny Gantz on Monday visits lab and describes the process of beginning of human trials as a “very significant moment”

3 years ago·India

Read Full Article

Hindustan Times

Israel’s Covid-19 vaccine ‘Brilife’ to begin human trials by end of October

Defence Minister Benny Gantz on Monday visited the IIBR and described the process of beginning of human trials as a “very significant moment” and “source of national pride” that can bring great news for Israel and the rest of the world.

3 years ago·New Delhi, India

Read Full Article

The Star Kuala Lumpur

Pfizer, BioNTech start combined trials of COVID-19 vaccine candidate in Japan

TOKYO (Reuters) - Pfizer Inc and BioNTech SE announced on Tuesday the start in Japan of combined Phase I and Phase II clinical trials of their mRNA vaccine candidate against the coronavirus. Read full story

3 years ago·Malaysia

Read Full Article

Financial Post

Pfizer, BioNTech start combined trials of COVID-19 vaccine candidate in Japan

TOKYO -- Pfizer Inc and BioNTech SE announced on Tuesday the start in Japan of combined Phase I and Phase II clinical trials of their mRNA vaccine candidate against the coronavirus. Read More

3 years ago·Canada

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.